Patients with Fulminant Myocarditis Supported with Extracorporeal Membrane Oxygenation: A Systematic Review and Meta-Analysis of Short-Term Mortality and Impact of Risk Factors
Fulminant myocarditis (FM) is a rare disease that may progress rapidly to refractory cardiogenic shock requiring temporary mechanical circulatory support. Venoarterial extracorporeal membrane oxygenation (VA-ECMO) has been used to provide biventricular support in these patients, however, studies have demonstrated conflicting results, likely due to small sample size. We conducted a systematic review and meta-analysis to evaluate short-term mortality after VA-ECMO in patients with FM.
Source: The Journal of Heart and Lung Transplantation - Category: Transplant Surgery Authors: J.K. Vishram-Nielsen, F. Billia, F. Foroutan, T.A. Buchan, J. Alvarez, A. Kinsella, K. Clark, A. Zhu, K. Lau, C. McGuinty, N. Aleksova, T. Francis, A. Stanimirovic, A. Malik, F. Gustafsson, H.J. Ross, E. Fan, J. Bielecki, V. Rac, V. Rao, A.C. Alba Tags: (1058) Source Type: research
More News: Cardiogenic Shock | Cardiology | Heart | Heart Transplant | Lung Transplant | Myocarditis | Rare Diseases | Study | Transplant Surgery | Transplants